What Caused The Sell-Off In Ionis Pharmaceuticals Stock?
- Tuesday, October 29, 2019, 7:13
- Market
- Add a comment
Ionis Pharmaceuticals (NASDAQ: IONS), a pharma company engaged in discovering and developing RNA-targeted therapeutics, has seen its stock decline by about 11% over the last week, trading at levels of around $55 currently. The decline is possibly due to a delay in the release of data…
About the Author
admin123 has written 23398 stories on this site.
